Lon Smith
Impact in
- Hematology top 1%
- Multiple Myeloma Research and Treatments
- Hematopoietic Stem Cell Transplantation
- Oncology top 10%
- Cancer Treatment and Pharmacology
- Peptidase Inhibition and Analysis
Papers in
-
- Multiple Myeloma Research and Treatments 5
- Platelet Disorders and Treatments 1
- Oncology 2
- Cancer Treatment and Pharmacology 1
- Peptidase Inhibition and Analysis 1
- Co-authors
- Raymond Alexanian (4 shared papers)Bart Barlogie (2 shared papers)Raymond Alexanian (1 shared paper)Leslie Smallwood (1 shared paper)Mark A. Pershouse (1 shared paper)Patricia Troncoso (1 shared paper)DONNAH M. JONES (1 shared paper)Lance C. Pagliaro (1 shared paper)
- Journals
- The American Journal of Medicine (1 paper)Journal of Clinical Investigation (1 paper)CA A Cancer Journal for Clinicians (1 paper)New England Journal of Medicine (1 paper)Blood (1 paper)
- Partner nations
- United StatesSpain
In The Last Decade
Lon Smith
6 papers receiving 766 citations
Lon Smith's Hit Papers
Peers
Comparison fields: 5 of 54
- Hematology 623
- Oncology 368
- Genetics 102
- Molecular Biology 405
- Pathology and Forensic Medicine 44
Countries citing papers authored by Lon Smith
This map shows the geographic impact of Lon Smith's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lon Smith with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lon Smith more than expected).
Fields of papers citing papers by Lon Smith
This network shows the impact of papers produced by Lon Smith. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lon Smith. The network helps show where Lon Smith may publish in the future.
Co-authors
The 22 scholars most cited alongside Lon Smith, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Effective Treatment of Advanced Multiple Myeloma Refractory to Alkylating Agents Hit paper breakdown → | 1984 | 534 |
| 2 | 1985 | 96 | |
| 3 | 2007 | 71 | |
| 4 | 1985 | 67 | |
| 5 | 1986 | 47 | |
| 6 | 1985 | 1 |
About Lon Smith
Lon Smith is a scholar working on Hematology, Oncology, Molecular Biology, Genetics and Pathology and Forensic Medicine, having authored 6 papers that have together received 816 indexed citations. Recurring topics across this work include Multiple Myeloma Research and Treatments (5 papers), Protein Degradation and Inhibitors (4 papers), Pancreatic function and diabetes (1 paper), Cancer Treatment and Pharmacology (1 paper), Lymphoma Diagnosis and Treatment (1 paper), Platelet Disorders and Treatments (1 paper), Peptidase Inhibition and Analysis (1 paper) and Myeloproliferative Neoplasms: Diagnosis and Treatment (1 paper). The work is most often cited by research in Hematology (623 citations), Oncology (368 citations), Genetics (102 citations), Molecular Biology (405 citations) and Pathology and Forensic Medicine (44 citations). Lon Smith has collaborated with scholars based in United States and Spain. Frequent co-authors include Raymond Alexanian, Bart Barlogie, Bart Barlogie, Raymond Alexanian, Leslie Smallwood, Mark A. Pershouse, Patricia Troncoso, DONNAH M. JONES, Lance C. Pagliaro and Paul F. Mathew. Their work appears in journals such as The American Journal of Medicine, Journal of Clinical Investigation, CA A Cancer Journal for Clinicians, New England Journal of Medicine and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.